- Home
- PLBC vs RNAC Comparison
PLBC vs RNAC Comparison
Compare PLBC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- RNAC
- Stock Information
- Founded
- PLBC 1980
- RNAC 2007
- Country
- PLBC United States
- RNAC United States
- Employees
- PLBC N/A
- RNAC N/A
- Industry
- PLBC Finance Companies
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- PLBC Finance
- RNAC Health Care
- Exchange
- PLBC Nasdaq
- RNAC Nasdaq
- Market Cap
- PLBC 236.7M
- RNAC 282.6M
- IPO Year
- PLBC 2005
- RNAC 2016
- Fundamental
- Price
- PLBC $45.89
- RNAC $13.32
- Analyst Decision
- PLBC Buy
- RNAC Strong Buy
- Analyst Count
- PLBC 4
- RNAC 5
- Target Price
- PLBC $55.75
- RNAC $40.00
- AVG Volume (30 Days)
- PLBC 14.5K
- RNAC 79.0K
- Earning Date
- PLBC 07-21-2025
- RNAC 08-07-2025
- Dividend Yield
- PLBC 2.62%
- RNAC N/A
- EPS Growth
- PLBC 3.33
- RNAC N/A
- EPS
- PLBC 4.95
- RNAC N/A
- Revenue
- PLBC $84,001,000.00
- RNAC $34,173,000.00
- Revenue This Year
- PLBC $19.95
- RNAC N/A
- Revenue Next Year
- PLBC $22.19
- RNAC N/A
- P/E Ratio
- PLBC $9.26
- RNAC N/A
- Revenue Growth
- PLBC 9.14
- RNAC 31.91
- 52 Week Low
- PLBC $35.16
- RNAC $8.46
- 52 Week High
- PLBC $51.33
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- PLBC 55.23
- RNAC 65.93
- Support Level
- PLBC $45.40
- RNAC $10.71
- Resistance Level
- PLBC $46.34
- RNAC $15.57
- Average True Range (ATR)
- PLBC 1.24
- RNAC 1.02
- MACD
- PLBC 0.13
- RNAC 0.34
- Stochastic Oscillator
- PLBC 52.66
- RNAC 63.74
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.